Clarametyx Biosciences’ Post

Through strategic alliances with exceptional lab partners around the world, LabConnect is raising the bar and delivering value through: ✅ World-class diagnostic services ✅ Innovative and specialized testing capabilities ✅ A commitment to quality, research, and education Learn more about how our partnerships with Cleveland Clinic and Labor Dr. Wisplinghoff can help you achieve clinical trial milestones faster. https://lnkd.in/gAuF_pU #ClinicalTrials #GlobalNetwork #ClinicalResearch

Through strategic alliances with exceptional lab partners around the world, LabConnect is raising the bar and delivering value through: ✅ World-class diagnostic services ✅ Innovative and specialized testing capabilities ✅ A commitment to quality, research, and education Learn more about how our partnerships with Cleveland Clinic and Labor Dr. Wisplinghoff can help you achieve clinical trial milestones faster. https://lnkd.in/gAuF_pU #ClinicalTrials #GlobalNetwork #ClinicalResearch #LivesDependOnIt 

Patients are at the core of clinical trials, and designing studies with their needs in focus can be a win-win. In a recent article in pharmaphorum, TransCelerate’s Executive Director of Portfolio Management, Jeneen Donadeo, highlights how simplifying trial processes—like using patient-friendly language and offering flexible participation options—can have real impact. Read here: https://lnkd.in/e7RcxwqE  

Overwhelmed in the JPM planning process? Check out this helpful guide. ⬇️

🧬 Want to accelerate your therapy’s journey from lab to clinic? At Advanced Therapies Week 2025, we’re deep diving into the most pressing challenges in advanced therapies: 🔑 Navigating complex regulatory pathways with updated insights 🔑 Securing funding and partnerships to take your novel therapies to market 🔑 Sharing clinical trial success stories that highlight how you can scale your innovations Whether it’s finding the right collaborators or maintaining your competitive edge, the agenda is packed with content to drive your business forward. 🎟️ Don’t wait—lock in the Super Early Bird rate before October 4th! https://ow.ly/P5QZ50Tu76e #ATW25 #RegulatoryUpdates #ClinicalTrials #PartneringOpportunities #AdvancedTherapiesWeek

𝘌𝘷𝘦𝘯𝘵 𝘙𝘦𝘤𝘢𝘱: 💬 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗩𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗨.𝗦. 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 “Commercial viability is the perfect balance of market and product viability.” Last week, we teamed up with Brightlands Maastricht Health Campus and RQR Advisors LLC to host an exclusive two-day workshop designed to help medical companies succeed in the U.S. market. Participants gained invaluable insights from industry experts at RQR Advisors, exploring topics like #FDA regulations, navigating coding, coverage, and #reimbursement, and understanding the essential calculus of commercial viability. We were honored to feature leaders like Michael Phalen, James (Jim) Sargent, and Dr. Kelvin Hensler, who provided perspectives ranging from strategic buyers to frontline physicians. This workshop truly delivered 360° knowledge to prepare innovators for success in one of the world’s most challenging healthcare markets. Want to stay connected or learn more about similar events? ➡️ Feel free to reach out to René Kessen! #Healthcareinnovation #Commercialviability #USMarket #Medtech #Brightlands #liof

Designing a clinical trials is no easy feat. Our CEO Shaherah Yancy is moderating a panel on the basics of designing, developing, and completing your clinical trials at Life Science Tennessee #LSTCON, and it's one of our core offerings at RLS. Click over to our website to learn how we can guide your #startup through your #clinicaltrial - at reasonable rates half that of most CROs.

Shayne Kennedy, Chair of Latham’s Healthcare & Life Sciences Industry Group, shares the upcoming capital markets trends for biotech deals in 2025 from the J.P. Morgan Healthcare Conference. https://lw.link/PYrKGy #jpm2025

Shayne Kennedy, Chair of Latham’s Healthcare & Life Sciences Industry Group, shares the upcoming capital markets trends for biotech deals in 2025 from the J.P. Morgan Healthcare Conference. https://lw.link/PzNBd7 #jpm2025

🌟 New A100 Newsletter Out Now! 🌟 This latest issue of The Association 100 is packed with insights to help your association engage, amplify and transform: 1️⃣ Celebrating Excellence in Association Communications: Discover the groundbreaking strategies of this year's A100 CommImpact Award winners. From advocacy to internal communications, learn how top associations like AAMFT, BSA | The Software Alliance, the American Medical Association, the American Society of Civil Engineers and more are setting new standards. 2️⃣ Navigating Open Access: Dive into a detailed roadmap for association publishers with David Jackson from American Society for Pharmacology and Experimental Therapeutics - ASPET, preparing for the 2025 open access mandates. 3️⃣ Engage Members to Amplify Your Message: Unlock powerful ways to engage your members and magnify your association's voice across platforms. 4️⃣ Making Your Issues More Relevant: Find out how to frame your association's issues to resonate more effectively with the media and public, enhancing your impact and visibility. 📚 Read on for actionable strategies and inspiring stories that can help propel your association forward. Don't miss out on these essential insights! 🔗 Read the latest issue: https://loom.ly/3WLnpCQ #AssociationLeadership #A100Newsletter #MemberEngagement #OpenAccess #CommImpact